Increased Levels of Interleukin-33 and Thymic Stromal Lymphopoietin in Exhaled Breath Condensate in Chronic Bronchial Asthma

International Archives of Allergy and Immunology

Volumn 169, Issue 1, 2016, Pages 51-56

  Glück, Joanna ^a   Rymarczyk, Barbara ^a   Kasprzak, Mirosława ^a   Rogala, Barbara ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Asthma; Epithelium; Exhaled breath condensate; Interleukin 33; Thymic stromal lymphopoietin

Indexed keywords

BUDESONIDE; IMMUNOGLOBULIN E; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR 4; INTERLEUKIN 25; INTERLEUKIN 33; NITRIC OXIDE; THEOPHYLLINE; THYMIC STROMAL LYMPHOPOIETIN; UNCLASSIFIED DRUG; CYTOKINE; IL33 PROTEIN, HUMAN;

ADULT; ARTICLE; ASTHMA; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; EXHALED BREATH CONDENSATE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RESPIRATORY TRACT INFLAMMATION; BREATH ANALYSIS; CHRONIC DISEASE; IMMUNOLOGY; MIDDLE AGED;

ADULT; ASTHMA; BREATH TESTS; CHRONIC DISEASE; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN-33; MALE; MIDDLE AGED;

EID: 84969509041     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000444017     Document Type: Article

References (34)

1. Lloyd CM, Saglani S: Asthma and allergy: the emerging epithelium. Nat Med 2010; 16:273-274.
2. Loxham M, Davies DE, Blume C: Epithelial function and dysfunction in asthma. Clin Exp Allergy 2014; 44:1299-1313.
3. Koppelman GH, Meyers DA, Howard TD, et al: Identification of PCDH1 as a novel susceptibility gene for bronchial hyperresponsive-ness. Am J Respir Crit Care Med 2009; 180: 929-935.
4. Watson B, Gauvreau GM: Thymic stromal lymphopoietin: a central regulator of allergic asthma. Expert Opin Ther Targets 2014; 18: 771-785.
5. Iijima H, Kaneko Y, Yamada H, Yatagai Y, Masuko H, Sakamoto T, Naito T, Hirota T, Tamari M, Konno S, Nishimura M, Noguchi E, Hizawa Nl: A distinct sensitization pattern associated with asthma and the thymic stro-mal lymphopoietin (TSLP) genotype. Aller-gol Int 2013; 62:123-130.
6. Birben E, Sahiner UM, Karaaslan C, Yavuz TS, Cosgun E, Kalayci O, Sackesen C: The genetic variants of thymic stromal lymphopoi-etin protein in children with asthma and allergic rhinitis. Int Arch Allergy Immunol 2014; 163:185-192.
7. Xu D, Chan WL, Leung BP, Huang Fp, Wheeler R, Piedrafita D, Robinson JH, Liew FY: Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J Exp Med 1998; 187:787-794.
8. Kamekura R, Kojima T, Takano K, Go M, Sawada N, Himi T: The role of IL-33 and its receptor ST2 in human nasal epithelium with allergic rhinitis. Clin Exp Allergy 2011; 42: 218-228
9. Milovanovic M, Volarevic V, Radosavljevic I, Pejnovic N, Arsenijevic N, Lukic ML: IL-33/ST2 axis in inflammation and immunopa-thology. Immunol Res 2012; 52:89-99.
10. Glück J, Rymarczyk B, Rogala B: Serum IL-33 but not ST2 level is elevated in intermittent allergic rhinitis and is a marker of the disease severity. Inflamm Res 2012; 5:547-550.
11. Oshikawa K, Kuroiwa K, Tago K, Iwahana H, Yanagisawa K, Ohno S, Tominaga SI, Sugi-yama Y: Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. Am J Respir Crit Care Med 2001; 164:277-281.
12. Ali M, Zhang G, Thomas WR, McLean CJ, Bizzintino JA, Laing IA, Martin AC, Gold-blatt J, Le Souëf PN, Hayden CM: Investigations into the role of ST2 in acute asthma in children. Tissue Antigens 2009; 73:206-212.
13. Préfontaine D, Nadigel J, Chouiali F, Audus-seau S, Semlali A, Chakir J, Martin JG, Hamid Q: Increased IL-33 expression by epithelial cells in bronchial asthma. J Allergy Clin Immunol 2010; 125;752-754.
14. Préfontaine D, Lajoie-Kadoch S, Foley S, Au-dusseau S, Olivenstein R, Halayko AJ, Le-mière C, Martin JG, Hamid Q: Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J Immunol 2009; 183:5094-5103.
15. Cheng D, Xue Z, Yi L, Shi H, Zhang K, Huo X, Bonser LR, Zhao J, Xu Y, Erle DJ, Zhen Gl: Epithelial interleukin-25 is a key mediator in th2-high, corticosteroid-responsive asthma. Respir Crit Care Med 2014; 190:639-648.
16. Munoz X, Bustamante V, Lopez-Campos J-L, Cruz M-J, Barreiro E: Usefulness of noninva-sive methods for the study of bronchial inflammation in the control of patients with asthma. In Arch Allergy Immunol 2015; 166: 1-12.
17. Loukides S, Kontogianni K, Hillas G, Horvath I: Exhaled breath condensate in asthma: from bench to bedside. Curr Med Chem 2011; 18: 1432-1443.
18. Antczak A, Górski P: Markers of pulmonary diseases in exhaled breath condensate. Int J Occup Med Environ Health 2002; 15:317-323.
19. Global Initiative for Asthma: Global strategy for asthma management and prevention. 2010. http://www.ginasthma.org/.
20. Horváth I, Hunt J, Barnes PJ, Alving K, Antczak A, Baraldi E: ATS/ERS Task Force on exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 2005; 26:523-548.
21. Miller MR, Hankinson J, Brusasco V, et al: Standardisation of spirometry. Eur Respir J 2005; 26:319-338.
22. Dreborg S, Frew A: Position papers: allergen standardization and skin tests. Allergy 1993; 48:9-82.
23. Cheng DT, Ma C, Niewoehner J, Dahl M, Tsai A, Zhang J, Gonsiorek W, Apparsundaram S, Pashine A, Ravindran P, Jung J, Hang J, Allard J, Bitter H, Tribouley C, Narula S, Wilson S, Fuentes MEDahl M, Tsai A, Zhang J, Gonsio-rek W, Apparsundaram S, Pashine A, Ravin-dran P, Jung J, Hang J, Allard J, Bitter H, Tri-bouley C, Narula S, Wilson S, Fuentes ME: Thymic stromal lymphopoietin receptor blockade reduces allergic inflammation in a cynomolgus monkey model of asthma. J Allergy Clin Immunol 2013; 132:455-462.
24. Kim YH, Yang TY, Park C-S, Ahn SH, Son BK, Kim JH, Lim DH, Jang TY: Anti-IL-33 antibody has a therapeutic effect in a murine model of allergic rhinitis. Allergy 2012; 49: 738-743.
25. Togbe D, Fauconnier L, Madouri F, Marchiol T, Chenuet P, Rouxel N, Ledru A, Erard F, Quesniaux V, Ryffel B: Thymic stromal lym-phopoietin enhances Th2/Th22 and reduces IL-17A in protease-allergen-induced airways inflammation. ISRN Allergy 2013; 7:971036.
26. Chen ZG, Zhang TT, Li HT, Chen FH, Zou XL, Ji JZ, Chen H: Neutralization of TSLP inhibit airway remodeling in a murine model of allergic asthma induced by chronic exposure to house dust mite. PLoS One 2013; 8:e51268.
27. Verheijden KAT, Akbari P, Willemsen LE, Kraneveld AD, Folkerts G, Garssen J, Fink-Gremmels J, Braber S: Inflammation-induced expression of the alarmin interleukin 33 can be suppressed by galacto-oligosaccharides. Int Arch Allergy Immunol 2015; 167:127-136.
28. Gauvreau GM, O'Byrne PM, Boulet LP, Wang Y, Cockcroft D, Bigler J, FitzGerald JM, Boe-digheimer M, Davis BE, Dias C, Gorski KS, Smith L, Bautista E, Comeau MR, Leigh R, Parnes JR: Effects of an anti-TSLP antibody on allergen-induced asthmatic responses. N Engl J Med 2014; 370:2102-2110.
29. Bartemes KR, Kephart GM, Fox SJ, Kita H: Enhanced innate type 2 immune response in peripheral blood from patients with asthma. J Allergy Clin Immunol 2014; 134:671-678.
30. Halim TY, Steer CA, Mathä L, Gold MJ, Martinez-Gonzalez I, McNagny KM, McKenzie AN, Takei F: Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation. Immunity 2014; 20:425-435.
31. Jackson DJ, Makrinioti H, Rana BM, Shamji BW, Trujillo-Torralbo MB, Footitt J, Jerico Del-Rosario, Telcian AG, Nikonova A, Zhu J, Aniscenko J, Gogsadze L, Bakhsoliani E, Traub S, Dhariwal J, Porter J, Hunt D, Hunt T, Hunt T, Stanciu LA, Khaitov M, Bartlett NW, Edwards MR, Kon OM, Mallia P, Papa-dopoulos NG, Akdis CA, Westwick J, Edwards MJ, Cousins DJ, Walton RP, Johnston SL: IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am J Respir Crit Care Med 2014; 190:1373-1382.
32. Tomasiak-Łozowska MM, Zietkowski Z, Przeslaw K, Tomasiak M, Skiepko R, Bodzen-ta-Lukaszyk A: Inflammatory markers and acid-base equilibrium in exhaled breath condensate of stable and unstable asthma patients. Int Arch Allergy Immunol 2012; 159: 121-129.
33. Zietkowski Z, Tomasiak-Lozowska MM, Skiepko R, Zietkowska E, Bodzenta-Lukaszyk A: Eotaxin-1 in exhaled breath condensate of stable and unstable asthma patients. Respir Res 2010; 11:110-119.
34. Hüttmann E-M, Greulich T, Hattesohl A, Schmid S, Noeske S, Herr C, John G, Jörres RA, Müller B, Vogelmeier C, Koczulla AR: Comparison of two devices and two breathing patterns for exhaled breath condensate sampling. PLoS One 2011; 11:e27467.